Several Things Cancer Patients Need to Know Before Seeking Medical Treatment in China
Top-ranking oncology hospitals and clinics:
https://www.medtourcn.com/introducing-chinas-top-10-leading-cancer-hospitals/
To reach out or visit the best oncology hospitals in China, contact us or send the electronic version or photo of your genetic testing report and diagnosis report.
email:doctor.huang@globecancer.com
WhatsApp:+8613717959070
Cost Comparison
Prices can vary depending on the institution and the specifics of the treatment but generally fall within these ranges:
-
Price Ranges : Oncology Treatments: $10,000 – $50,000
In general, medical procedures in China cost 30% to 70% less than in the United States or Western Europe. Using CAR-T as an Example: CAR-T therapy has always been notorious for its high prices. How expensive is it exactly?
Solely considering the drugs themselves, Novartis’ Kymriah is priced the highest, exceeding 3 million RMB, while other CAR-T therapies in the United States are priced at over 2 million RMB.
In contrast, three domestically produced Chinese CAR-T therapies are all priced at less than 1.3 million RMB, only one-third of Novartis’ Kymriah. Specifically, JW Therapeutics’ Carteyva (Relmacabtagene autoleucel) is priced at 1.29 million RMB, FOSUNKITE’s Yescarta (Axicabtagene ciloleucel) at 1.2 million RMB, and FUCASO (Equecabtagene ciloleucel) by IASO Biotech at 1.166 million RMB. Moreover, just a few days ago, Inaticabtagene Autoleucel, independently developed by Juventas Biotech, has been approved for market release, marking a qualitative breakthrough in the price of domestically produced Chinese CAR-T therapies, priced at 999,000 RMB per unit.